Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis
Hormonal therapy use in rectovaginal endometriosis patients was associated with reduced densities of sympathetic, parasympathetic, and sensory nerve fibers, and lower NGF expression in DIE lesions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (30)
- An Investigation of the Relationship between Pelvic Pain and Density of Nerve Fibers in Peritoneal Lesions of Endometriosis via openalex
- Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis via openalex
- Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via openalex
- Endometriosis: the consequence of neurological dysfunction? via openalex
- Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants via openalex
- High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis via openalex
- Hyperinnervation in Intestinal Deep Infiltrating Endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex
- Nerve fibres in peritoneal endometriosis via openalex
- Neuroendocrine cells in eutopic endometrium of women with endometriosis via openalex
- Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex
- Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions via openalex
- Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex
- Radical excision of rectovaginal endometriosis results in high rate of pain relief – results of a long‐term follow‐up study via openalex
- Rectovaginal Endometriosis–Characteristics of Operative Treatment and Factors Predicting Bowel Resection via openalex
- The Characteristic Expression of CD3+ T Cells, CD8+ T Cells and CD57+ NK Cells in Distinct Zones of Peritoneal Endometriotic Lesions via openalex
- Treatment of symptomatic rectovaginal endometriosis with an estrogen–progestogen combination versus low-dose norethindrone acetate via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2024418590 via openalex
- W2152955646 via openalex
- W2329132278 via openalex
- W2477008945 via openalex
- W4211081176 via openalex
- W2006568053 via openalex
- W2138118457 via openalex
- W2033247060 via openalex
Cited by (35)
- Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways 2026
- Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for Progress 2025
- Multifaceted analysis in the surgery of the endometriotic cyst and the significance of the resection of the median pelvic endometriosis 2024
- Evaluation of the Characteristics of Ovarian Endometriomas in Patients with Endometriosis: Efficacy of a Low-Dose Estrogen/Progestogen Combination 2023
- Digestive system deep infiltrating endometriosis: What do we know 2023
- Standardized protocol for quantification of nerve bundle density as a biomarker for endometriosis 2023
- AVALIAÇÃO DE BIOMARCADORES EM MULHERES COM ENDOMETRIOSE E DOR USUÁRIAS DO IMPLANTE COM ETONOGESTREL OU SISTEMA INTRAUTERINO COM LEVONORGESTREL: ENSAIO CLÍNICO RANDOMIZADO 2022
- Resection of the posterior vaginal fornix and retrocervical endometriotic lesions in the median part of the pelvis 2022
- Recurrent Catamenial Pneumothorax After Multiple Chest Tube Placements, Pleurodesis and Vats 2022
- Estro-Progestins and Pain Relief in Endometriosis 2022
- Estrogen and progesterone receptors in endometriosis 2021
- Non-contraceptive Benefits of Hormonal Methods 2021
- Faculty Opinions recommendation of Autonomic nervous system and inflammation interaction in endometriosis-associated pain. 2021
- Autonomic nervous system and inflammation interaction in endometriosis-associated pain 2020
- Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model 2020
- Douleurs et endométriose 2020
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Pathogenesis of bowel endometriosis 2020
- Medical management of deeply infiltrating endometriosis - 7 year experience in a tertiary endometriosis centre in London 2019
- Endometriotic lesions 2019
- Hormonal Therapy in Women of Reproductive Age with Endometriosis: an Update 2019
- Semi-Automated and Manual Methods for Counting Cells Expressing P75 Receptor in Endometriotic Lesions 2018
- Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial 2018
- Avaliação de biomarcadores em mulheres com endometriose e dor usuárias do implante liberador de etonogestrel ou sistema intrauterino liberador de levonorgestrel = Assessment of biomarkers among women with endometriosis-associated pain users of the etonogestrel-releasing contraceptive implant or 52-mg levonorgestrel releasing intrauterine system: randomized clinical trial 2018
- Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence 2018
- The Long-Term Footprint of Endometriosis: Population-Based Cohort Analysis Reveals Increased Pain Symptoms and Decreased Pain Tolerance at Age 46 Years 2018
- Conservative treatment of deep infiltrating endometriosis: review of existing options 2017
- Pharmacological treatment of endometriosis: review of current and new options for treatment 2016
- Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells 2016
- Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study 2016
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Medikamentozno zdravljenje endometrioze: pregled stanja in nove možnosti zdravljenja 2016
- Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis 2016
- Nerve Bundles and Deep Dyspareunia in Endometriosis 2015
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:58.238279+00:00